This research aims to determine the significance of red cell distribution width and mean platelet volume as mortality indicators in COVID-19 patients.
Retrospective cohort analysis of COVID-19 patients
Assessment of red cell distribution width and mean platelet volume from blood tests
Correlations between RDW, MPV, and clinical outcomes
Higher red cell distribution width and mean platelet volume correlate with increased mortality
Early identification of these markers may lead to timely interventions
Findings suggest potential for improving patient outcomes with better monitoring
Abstract
RDW and MPV, routinely available from blood tests, may help identify early clinical deterioration, supporting timely interventions to improve outcomes.